{"id":111642,"name":"THE UNIVERSITY OF CHICAGO MEDICAL CENTER","slug":"the-university-of-chicago-medical-center","state":"IL","description":"Healthcare","totalSpending":1342000,"filings":23,"yearlySpending":[{"year":2018,"income":153000},{"year":2019,"income":216000},{"year":2020,"income":152000},{"year":2021,"income":190000},{"year":2022,"income":230000},{"year":2024,"income":129000},{"year":2025,"income":272000}],"firms":["CARMEN GROUP INCORPORATED"],"lobbyists":["WILLIAM SIGNER"],"issues":["HCR"],"sampleDescriptions":["Medicare, Medicaid, NIH Funding Medical Education Funding Hospital Outpatient Department, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 340B, American Health Care Act of 2017 (AHCA); Better Care Reconciliation Act (BCRA)","Medicare, Medicaid, NIH Funding Medical Education Funding, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 340B","Medicare, Medicaid, NIH Funding Medical Education Funding, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 340B; HR 4392","Medicare, Medicaid, NIH Funding Medical Education Funding, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 3408; HR 4392; Drug Pricing","Medicare, Medicaid, NIH Funding Medical Education Funding, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 3408; HR 4392; Drug Pricing; Surprise Billing","Medicare, Medicaid, NIH Funding Medical Education Funding, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 3408; HR 4392; Drug Pricing; Surprise Billing; H.R. 3","Medicare, Medicaid, NIH Funding Medical Education Funding, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 340B; HR 4392; Drug Pricing; Surprise Billing; H.R. 3; Hospital Outpatient Reimbursement","Medicare, Medicaid, NIH Funding Medical Education Funding, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 340B; HR 4392; Drug Pricing; Surprise Billing; H.R. 3; Hospital Outpatient Reimbursement; CARES act","Medicare, Medicaid, NIH Funding Medical Education Funding, Helping Hospital Improve Patient Care Act HR 5273, Funding FY 2019 Budget, Medicare Redesign; 340B; HR 4392; Drug Pricing; Surprise Billing; H.R. 3; Hospital Outpatient Reimbursement; CARES act; The HEROS Act; HR 133","Medicare, Medicaid, NIH Funding; Medical Education Funding; Helping Hospital Improve Patient Care Act; Medicare Redesigns; 340B; HR 4392; Drug Pricing; Surprise Billing; HR 3; Hospital Outpatient Reimbursement; FY 2021 Omnibus Appropriations and Coronavirus Relief Bill HR 133","Medicare, Medicaid, NIH Funding; Medical Education Funding; Helping Hospital Improve Patient Care Act; Medicare Redesigns; 340B; HR 4392; Drug Pricing; Surprise Billing; HR 3; Hospital Outpatient Reimbursement; FY 2021 Omnibus Appropriations; Extension of Telehealth COVID-19 rules","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; HR 4392; Drug Pricing; Surprise Billing; HR 3; Hospital Outpatient Reimbursement; FY 2022 Omnibus Appropriations; Extension of Telehealth COVID-19 rules - The CONNECT for Health of 2021 HR 2903;","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; HR 4392; Drug Pricing; HR 3; Hospital Outpatient Reimbursement; FY 2022 Omnibus Appropriations; Extension of Telehealth COVID-19 rules - The CONNECT for Health of 2021 HR 2903; VALID Act","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; HR 4392; Drug Pricing; HR 3; Hospital Outpatient Reimbursement; FY 2022 Omnibus Appropriations; Extension of Telehealth COVID-19 rules - The CONNECT for Health of 2021 HR 2903; VALID Act; Salsa Act H.R. 8188 / S.4449","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; Drug Pricing; H.R. 3; Hospital Outpatient Reimbursement; FY 2022 Omnibus Appropriations; Extension of Telehealth COVID-19 rules - Telehealths; VALID Act; Salsa Act H.R. 1835; Pending FDA regulation of LDTs","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; Drug Pricing; H.R. 3; Hospital Outpatient Reimbursement; FY 2022 Omnibus Appropriations; Extension of Telehealth COVID-19 rules - Telehealth; VALID Act; Salsa Act H.R. 1835; Pending FDA regulation of LDTs","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; Drug Pricing; H.R. 3; Hospital Outpatient Reimbursement; FY 2022 Omnibus Appropriations; Extension of Telehealth COVID-19 rules - Telehealth; VALID Act; Salsa Act H.R. 1835; Pending FDA regulation of LDTS","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; Drug Pricing; H.R. 3; Hospital Outpatient Reimbursement; FY 2026 Appropriations; Extension of Telehealth COVID-19 rules - Telehealth; Salsa Act; Pending FDA regulation of LDTS; One Big Beautiful Bill","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; Drug Pricing;Hospital Outpatient Reimbursement; FY 2026 Appropriations; Extension of Telehealth COVID-19 rules - Telehealth; Pending FDA regulation of LDTS","Medicare, Medicaid, NIH Funding; Medical Education Funding; 340B; Drug Pricing;Hospital Outpatient Reimbursement; FY 2026 Appropriations"],"years":[2018,2019,2020,2021,2022,2024,2025]}